论文部分内容阅读
血清溶菌酶是人体内非特异的免疫物质之一,约有75～80%来自血液及骨髓的中性粒细胞和单核细胞,而在淋巴细胞、嗜酸性及嗜碱性粒细胞中没有此酶。1966年Osserman等报告急性单核细胞性白血病患者的血清和尿中出现大量溶菌酶,以后很多工作表明,根据白血病患者的血清溶菌酶测定有助于对淋巴细胞性和非淋巴细胞性白血病的鉴别诊断,并且观察血清溶菌酶的动态变化,在判断予后
Serum lysozyme is one of the non-specific immune substances in human body, with about 75-80% of neutrophils and monocytes from blood and bone marrow, but not from lymphocytes, eosinophils and basophils Enzymes. In 1966, Osserman et al. Reported a large amount of lysozyme in the serum and urine of patients with acute monocytic leukemia. Since then, much work has been done on the determination of lymphocytic and non-lymphocytic leukemia according to the determination of serum lysozyme in leukemia patients Diagnosis, and observe the dynamic changes of serum lysozyme, after the judge